Get started
Author

Kristina Schwamborn

Observed names: K Schwamborn, K. Schwamborn, Kristina Schwammborn, Schwamborn, K., Schwamborn, Kristina, Schwammborn, Kristina
Observed institutions: Vanderbilt University, TUM Klinikum, Universitätsklinikum Aachen, Asklepios Klinik Sankt Augustin, Jena University Hospital, National Cancer Institute, Pathologisches Institut, University of Regensburg, Technical University of Munich, RWTH Aachen University
ORCID: 0000-0003-3717-0823
Observed ORCID: 0000-0003-3717-0823
OpenAlex ID: A5014183136
Molecular imaging by mass spectrometry — looking beyond classical histology
2010 · Kristina Schwamborn, Richard M. Caprioli · Nature reviews. Cancer · 354
99mTechnetium-based Prostate-specific Membrane Antigen–radioguided Surgery in Recurrent Prostate Cancer
2018 · Tobias Maurer, Stephanie Robu, et al. · European Urology · 243
Membranous NECTIN-4 Expression Frequently Decreases during Metastatic Spread of Urothelial Carcinoma and Is Associated with Enfortumab Vedotin Resistance
2022 · Niklas Klümper, Damian J. Ralser, et al. · Clinical Cancer Research · 227
PDF
In vivo molecular imaging of chemokine receptor CXCR4 expression in patients with advanced multiple myeloma
2015 · Kathrin Philipp‐Abbrederis, Ken Herrmann, et al. · EMBO Molecular Medicine · 222
PDF
Mass Spectrometry Imaging and Integration with Other Imaging Modalities for Greater Molecular Understanding of Biological Tissues
2018 · Tiffany Porta Siegel, Gregory Hamm, et al. · Molecular Imaging and Biology · 187
PDF
Identifying prostate carcinoma by MALDI-Imaging
2007 · Kristina Schwamborn, René Krieg, et al. · International Journal of Molecular Medicine · 168
68Ga-PSMA-HBED-CC PET for Differential Diagnosis of Suggestive Lung Lesions in Patients with Prostate Cancer
2015 · Thomas Pyka, Gregor Weirich, et al. · Journal of Nuclear Medicine · 134
PDF
MALDI Imaging Mass Spectrometry – Painting Molecular Pictures
2010 · Kristina Schwamborn, Richard M. Caprioli · Molecular Oncology · 126
Protein quantification and its tolerance for different interfering reagents using the BCA-method with regard to 2D SDS PAGE
2005 · Rene C. Krieg, Yan Dong, et al. · Journal of Biochemical and Biophysical Methods · 124
Imaging of Intact Tissue Sections: Moving beyond the Microscope
2011 · Erin H. Seeley, Kristina Schwamborn, et al. · Journal of Biological Chemistry · 111
PDF
Value of 111 In‐prostate‐specific membrane antigen ( PSMA )‐radioguided surgery for salvage lymphadenectomy in recurrent prostate cancer: correlation with histopathology and clinical follow‐up
2016 · Isabel Rauscher, Charlotte Düwel, et al. · British Journal of Urology · 104
Radical Prostatectomy Without Prior Biopsy Following Multiparametric Magnetic Resonance Imaging and Prostate-specific Membrane Antigen Positron Emission Tomography
2021 · Valentin H. Meissner, Isabel Rauscher, et al. · European Urology · 101
Prognostic Impact of a 12-gene Progression Score in Non–muscle-invasive Bladder Cancer: A Prospective Multicentre Validation Study
2017 · Lars Dyrskjøt, Thomas Reinert, et al. · European Urology · 99
Site‐to‐Site Reproducibility and Spatial Resolution in MALDI–MSI of Peptides from Formalin‐Fixed Paraffin‐Embedded Samples
2018 · Alice Ly, Rémi Longuespée, et al. · PROTEOMICS - CLINICAL APPLICATIONS · 92
PDF
Reliable Entity Subtyping in Non-small Cell Lung Cancer by Matrix-assisted Laser Desorption/Ionization Imaging Mass Spectrometry on Formalin-fixed Paraffin-embedded Tissue Specimens
2016 · Mark Kriegsmann, Rita Casadonte, et al. · Molecular & Cellular Proteomics · 90
The added value of PSMA PET/MR radiomics for prostate cancer staging
2021 · Esteban Lucas Solari, Andrei Gafita, et al. · European Journal of Nuclear Medicine and Molecular Imaging · 87
PDF
Opposing role of Notch1 and Notch2 in a KrasG12D-driven murine non-small cell lung cancer model
2014 · A Baumgart, P K Mazur, et al. · Oncogene · 83
Interlaboratory concordance of PD ‐L1 immunohistochemistry for non‐small‐cell lung cancer
2017 · Andreas H Scheel, Gudrun Baenfer, et al. · Histopathology · 80
Imaging mass spectrometry in biomarker discovery and validation
2012 · Kristina Schwamborn · Journal of Proteomics · 70
Serum Proteomic Profiling in Patients with Bladder Cancer
2009 · Kristina Schwamborn, René C. Krieg, et al. · European Urology · 70
MALDI imaging mass spectrometry — From bench to bedside
2016 · Kristina Schwamborn, Mark Kriegsmann, et al. · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · 64
Expert-Guided Large Language Models for Clinical Decision Support in Precision Oncology
2024 · Jacqueline Lammert, Tobias Dreyer, et al. · JCO Precision Oncology · 63
Extracellular Matrix Imaging of Breast Tissue Pathologies by MALDI–Imaging Mass Spectrometry
2018 · Peggi M. Angel, Kristina Schwamborn, et al. · PROTEOMICS - CLINICAL APPLICATIONS · 59
Histone acetylation and histone acetyltransferases show significant alterations in human abdominal aortic aneurysm
2016 · Yanshuo Han, Fadwa Tanios, et al. · Clinical Epigenetics · 58
PDF
Multicentric analytical comparability study of programmed death-ligand 1 expression on tumor-infiltrating immune cells and tumor cells in urothelial bladder cancer using four clinically developed immunohistochemistry assays
2019 · Kristina Schwamborn, Johannes U Ammann, et al. · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · 56
PDF
Works count: 182
Citation count: 4,268
H-index: 34
I10-index: 71
Year
Topic
Type